CE Education
A Practical Guide to PET-Adapted Therapy for Hodgkin Lymphoma
Peter Johnson, MD
|
CE Education
2016 EHA Annual Meeting Highlights in HL
Peter Borchmann, MD; Paul Bröckelmann, MD; Astrid Pavlovsky, MD; and Anas Younes, MD
|
CE Education
First-line Treatment of HL: Differential Treatment Strategies in Newly Diagnosed Patients with Early- versus Advanced-Stage Disease
Andrew M. Evens, DO, MSc, FACP
|
CE Education
Aiming for a Higher Cure Rate: Strategies for Salvage Treatment at Relapse in HL
Robert W. Chen, MD
|
Case Discussion
Case Study of a Newly Diagnosed HL Patient: The Role of CD30 from Diagnosis to Treatment
Andreas Engert, MD
|
FAQ Library
What new/emerging treatments for relapsed/refractory HL are most likely to improve patient outcomes?
Robert W. Chen, MD
|
FAQ Library
What are the roles of immunohistochemistry studies versus flow cytometry results in diagnosing HL?
Andrew M. Evens, DO, MSc, FACP
|
FAQ Library
What treatment approaches may increase chances for a higher cure rate in patients with R/R HL?
Robert W. Chen, MD
|
FAQ Library
When is it appropriate and/or necessary to utilize mRNA testing in the diagnosis and staging of HL?
Which factors are more important when developing treatment plans for the newly diagnosed HL patient?
Andrew M. Evens, DO, MSc, FACP
|
